Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials
Overview
Zymeworks is a biotechnology company founded in Vancouver in 2003. It designs multifunctional antibody therapeutics using its own computational protein engineering platform. The company is listed on Nasdaq and partners with large pharmaceutical firms.
News
Ziihera (zanidatamab-hrii) plus Chemotherapy Demonstrates Statistically Significant Overall Survival Benefit Versus Trastuzumab plus Chemotherapy in First-Line HER2+ Advanced GEA
The post Ziihera (zanidatamab-hrii) plus Chemotherapy Demonstrates Statistically Significant Overall Survival Benefit Versus Trastuzumab plus Chemotherapy in First-Line HER2+ Advanced GEA appeared first on Zymeworks.
Read more
Report
U.S. FDA Approves Ziihera (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma
The post U.S. FDA Approves Ziihera (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma appeared first on Zymeworks.
Read more
Report
Zymeworks Announces Participation in Upcoming Investor Conferences
The post Zymeworks Announces Participation in Upcoming Investor Conferences appeared first on Zymeworks.
Read more
Report
Zymeworks Provides Corporate Update and Reports Second Quarter 2026 Financial Results
The post Zymeworks Provides Corporate Update and Reports Second Quarter 2026 Financial Results appeared first on Zymeworks.
Read more
Report
Zymeworks to Report Second Quarter 2026 Financial Results on August 6, 2026
The post Zymeworks to Report Second Quarter 2026 Financial Results on August 6, 2026 appeared first on Zymeworks.
Read more
Report
Pro access
Upgrade to see all 12 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
Technologies
Data Science
ETL/ELT
Other
Model Context Protocol
SharePoint
Stack modernity
71/100
How modern this stack is, based on technology relevance, AI adoption and the share of legacy tools.
In-demand technologies
Model Context Protocol
1 job
Required
ETL/ELT
1 job
Required
SharePoint
1 job
Required
Salary medians are calculated from this company's open jobs and compared with the market.
Industry adoption
ETL/ELT
8%
Model Context Protocol
5%
SharePoint
3%
Share of companies in the same industry that use each technology.
Stack changes
SharePoint
Sep 2026
Model Context Protocol
Sep 2026
ETL/ELT
Sep 2026
Technologies recently added to or removed from this company's stack - a signal of tech migrations and new initiatives.
Vantor
American Express Technology
Xylem
Arcadis
Sourcefit
Lam Research
Growth
Hiring Momentum
83/100
Scaling fast
Open positions
8
4 opened / 0 closed in 30 days
ATS activity
Every ~10 hours
Today
Hiring Dynamics
+100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Early Careers
38% ▲
Science & Research
25%
Product
13% ▼
Management
13% ▼
Sales
13% ▼
Actively hiring for Early Careers (+3 in 30 days)
Activity Timeline
Added SharePoint to stack
Sep 2026
Added Model Context Protocol to stack
Sep 2026
Added ETL/ELT to stack
Sep 2026
Offices
Where the company hires and what each office is for
Cities
3
Hiring now
2
Countries
3
Busiest office
Vancouver
Vancouver
Canada
HQ
Zymeworks Inc.
6 open roles 6 posted in 90 days 17% engineering
hires for Early Careers, Product, Management
114 East 4th Avenue, Suite 800, Vancouver, BC, Canada V5T 1G4
Bellevue
United States
1 open roles 1 posted in 90 days 100% engineering
hires for Science & Research
Singapore
Singapore
Regional office
Zymeworks Lifesciences Pte. Ltd.
Science Park 1, 2 Science Park Drive, Singapore 112888
Jobs
≈ $120k – $209k per year (Estimated) • Equity • In office • Full-Time • 8+ years exp • Vancouver
Model Context Protocol
Analytics
ETL/ELT
Management
SharePoint
Apply